Department of Infectious Diseases

Medicine & Life Sciences

1. HIV 100%
2. Hepacivirus 76%
3. Denmark 70%
4. Cohort Studies 46%
5. Genotype 32%
6. HIV-1 30%
7. Coronavirus 27%
8. Mortality 25%
9. Infections 25%
10. Population 23%
11. HIV Infections 21%
12. Viruses 21%
13. Confidence Intervals 20%
14. Chronic Hepatitis C 20%
15. Highly Active Antiretroviral Therapy 19%
16. Refugees 19%
17. SARS Virus 18%
18. Bacteremia 18%
19. Virus Diseases 18%
20. CD4 Lymphocyte Count 17%
21. Therapeutics 17%
22. Vaccines 17%
23. Antiviral Agents 16%
24. Severe Acute Respiratory Syndrome 15%
25. Incidence 15%
26. T-Lymphocytes 13%
27. Neutralizing Antibodies 13%
28. Tuberculosis 13%
29. RNA 12%
30. Cell Culture Techniques 11%
31. Staphylococcus aureus 11%
32. Pneumonia 10%
33. Comorbidity 10%
34. Viral Load 10%
35. Protease Inhibitors 10%
36. Mutation 10%
37. GS-5734 9%
38. Antibodies 9%
39. Hepatitis C 9%
40. Odds Ratio 9%
41. Randomized Controlled Trials 8%
42. Child 8%
43. Acquired Immunodeficiency Syndrome 8%
44. Vaccination 8%
45. Urokinase Plasminogen Activator Receptors 8%
46. Systematic Reviews 8%
47. Delivery of Health Care 8%
48. Pharmaceutical Preparations 7%
49. Placebos 7%
50. Meningitis 7%
51. Ribavirin 7%
52. Epitopes 7%
53. Pneumococcal Infections 7%
54. Lipodystrophy 7%
55. Coronavirus Infections 7%
56. Cross-Sectional Studies 7%
57. Genome 6%
58. Hepatitis 6%
59. Biomarkers 6%
60. Liver 6%
61. Fibrosis 6%
62. Health 6%
63. Hospitalization 6%
64. Bacterial Meningitides 5%
65. Hepatitis B virus 5%
66. Serogroup 5%
67. Observational Studies 5%
68. Virion 5%
69. Communicable Diseases 5%
70. Coinfection 5%
71. Lung 5%
72. Cardiovascular Diseases 5%
73. Chronic Obstructive Pulmonary Disease 5%
74. Prospective Studies 5%
75. Proteins 5%
76. Fecal Microbiota Transplantation 5%
77. Registries 5%
78. Liver Diseases 5%
79. Pandemics 5%
80. Inflammation 5%
81. Guidelines 5%
82. Meta-Analysis 5%
83. Anti-Bacterial Agents 5%
84. Reverse Transcriptase Inhibitors 5%
85. Genes 5%
86. Logistic Models 5%